会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COMBINATIONS COMPRISING EPOTHILONES AND PHARMACEUTICAL USES THEREOF
    • 包含EPOTHILONES及其药物用途的组合
    • US20110033458A1
    • 2011-02-10
    • US12908533
    • 2010-10-20
    • John Arthur HohnekerJulie Ann MillerJohn David RothermelMarkus Wartmann
    • John Arthur HohnekerJulie Ann MillerJohn David RothermelMarkus Wartmann
    • A61K39/395A61K31/427A61P35/00
    • C07K16/3015A61K31/426A61K31/427A61K39/39558A61K45/06A61K2039/505C07D417/06A61K2300/00
    • The invention relates to a pharmaceutical combination which comprises (a) a HER-1 or a HER-2 antibody or (b) at least one antineoplastic agent selected from the group consisting of aromatase inhibitors, antiestrogens, topoisomerase I inhibitors, topoisomerase II inhibitors, microtubule active agents, protein kinase C inhibitors, anti-angiogenic compounds, gonadorelin agonists, anti-androgens, histone deacetylase inhibitors and S-adenosylmethionine decarboxylase inhibitors; and (c) an epothilone derivative of formula I and optionally at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular, for the treatment of a proliferative disease, especially a solid tumor disease; a pharmaceutical composition comprising such a combination; the use of such a combination for the preparation of a medicament for the treatment of a proliferative disease; a commercial package or product comprising such a combination as a combined preparation for simultaneous, separate or sequential use; and to a method of treatment of a warm-blooded animal, especially a human.
    • 本发明涉及药物组合,其包含(a)HER-1或HER-2抗体或(b)至少一种抗肿瘤剂,其选自芳香酶抑制剂,抗雌激素,拓扑异构酶I抑制剂,拓扑异构酶II抑制剂, 微管活性剂,蛋白激酶C抑制剂,抗血管生成化合物,促性腺激素激动剂,抗雄激素,组蛋白脱乙酰酶抑制剂和S-腺苷甲硫氨酸脱羧酶抑制剂; 和(c)式I的埃坡霉素衍生物和任选的至少一种用于同时,分别或顺序使用的药学上可接受的载体,特别是用于治疗增殖性疾病,特别是实体肿瘤疾病; 包含这种组合的药物组合物; 使用这种组合来制备用于治疗增殖性疾病的药物; 包括作为用于同时,分开或顺序使用的组合制剂的组合的商业包装或产品; 以及治疗温血动物,特别是人的方法。